BFEC
GNLX icon

Benjamin F. Edwards & Company’s Genelux GNLX Stock Holding History

Benjamin F. Edwards & Company’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-110
Closed -$2K – 2160
2023
Q4 		$2K Hold
110
– – ﹤0.01% 1988
2023
Q3 		$3K Buy
+110
New +$2.79K ﹤0.01% 1634

Other funds holding GNLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $388M AUM 20.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Benjamin F. Edwards & Company's GNLX Position: Q1 2024 in Review

Benjamin F. Edwards & Company sold out of Genelux (GNLX) in Q1 2024, closing a stake of 110 shares — an estimated $2K sold.

Benjamin F. Edwards & Company first reported a position in GNLX in Q3 2023 and held it in 2 quarters. The position peaked at $3K in Q3 2023. 67 funds tracked by Wall St. Rank hold GNLX as of Q1 2024.

  • Benjamin F. Edwards & Company reported no remaining Genelux position as of Q1 2024 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 110 Genelux shares in Q1 2024, an estimated $2K.
  • Benjamin F. Edwards & Company first reported a position in Genelux in Q3 2023 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's Genelux position peaked at $3K in Q3 2023.
  • 67 funds tracked by Wall St. Rank held Genelux as of Q1 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2024, filed 29 Apr 2024.